Overview
Jardiance 10 mg Tablets contain Empagliflozin, an SGLT2 (sodium-glucose co-transporter 2) inhibitor used to manage type 2 diabetes mellitus and reduce the risk of cardiovascular death in adults with both diabetes and heart disease. It works by blocking glucose reabsorption in the kidneys, leading to glucose being excreted through urine. Jardiance is typically prescribed as a once-daily oral therapy.





